Aevi Genomic Medicine to Present at the The 2018 JMP Securities Life Sciences Conference
Aevi Genomic Medicine Provides Update on Sample Size Re-estimation for Phase 2 ASCEND Trial in ADHD
Aevi Genomic Medicine to Present at the Jefferies 2018 Global Healthcare Conference
Leaders in genetic science and commercial drug development
Discover the future of novel genetic therapies currently being researched by Aevi Genomic Medicine.
Presentations, information, and news